The Central Drugs Standard Control Organization (CDSCO) on May 15, 2024, notified regarding the retention of licenses or certificates under Medical Devices Rules, 2017.
The Following has been stated namely: -
• It states that for obtaining the license for manufacturing or import of medical devices and for medical devices testing laboratory, all the stakeholders shall deposit the requisite fees in the appropriate account of the Government before the stipulated timeline under MDR, 2017, or unless it shall be suspended or cancelled by the licensing authority.
• It also states that stakeholders shall submit the application to the Licensing Authority to maintain the continuity of the product in the market.
[Notification no. - MED-15/35/2024-eoffice]
